Hyper-activation of the pathway components such as MST1 and the consequent inhibition of YAP have been noted in several neurodegenerative disease models (Matsumoto et al., 2014; Yamanishi et al., 2017; Mueller et al., 2018; Tanaka et al., 2020). This evidence concerns the gene MST1 and neurodegenerative disease.